1. Home
  2. GSK vs SLB Comparison

GSK vs SLB Comparison

Compare GSK & SLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSK
  • SLB
  • Stock Information
  • Founded
  • GSK 1715
  • SLB 1926
  • Country
  • GSK United Kingdom
  • SLB United States
  • Employees
  • GSK N/A
  • SLB N/A
  • Industry
  • GSK Biotechnology: Pharmaceutical Preparations
  • SLB Oilfield Services/Equipment
  • Sector
  • GSK Health Care
  • SLB Energy
  • Exchange
  • GSK Nasdaq
  • SLB Nasdaq
  • Market Cap
  • GSK 77.4B
  • SLB 45.8B
  • IPO Year
  • GSK N/A
  • SLB N/A
  • Fundamental
  • Price
  • GSK $38.55
  • SLB $36.16
  • Analyst Decision
  • GSK Hold
  • SLB Strong Buy
  • Analyst Count
  • GSK 2
  • SLB 21
  • Target Price
  • GSK N/A
  • SLB $52.10
  • AVG Volume (30 Days)
  • GSK 5.2M
  • SLB 15.7M
  • Earning Date
  • GSK 07-30-2025
  • SLB 07-18-2025
  • Dividend Yield
  • GSK 4.13%
  • SLB 3.06%
  • EPS Growth
  • GSK N/A
  • SLB N/A
  • EPS
  • GSK 0.98
  • SLB 2.96
  • Revenue
  • GSK $40,735,668,430.00
  • SLB $36,072,000,000.00
  • Revenue This Year
  • GSK $6.70
  • SLB N/A
  • Revenue Next Year
  • GSK $5.42
  • SLB $3.58
  • P/E Ratio
  • GSK $18.88
  • SLB $12.62
  • Revenue Growth
  • GSK 2.57
  • SLB 5.76
  • 52 Week Low
  • GSK $31.72
  • SLB $31.11
  • 52 Week High
  • GSK $44.67
  • SLB $50.94
  • Technical
  • Relative Strength Index (RSI)
  • GSK 45.78
  • SLB 63.44
  • Support Level
  • GSK $37.94
  • SLB $35.70
  • Resistance Level
  • GSK $40.11
  • SLB $36.71
  • Average True Range (ATR)
  • GSK 0.56
  • SLB 1.12
  • MACD
  • GSK -0.01
  • SLB 0.28
  • Stochastic Oscillator
  • GSK 28.23
  • SLB 93.63

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

About SLB Schlumberger N.V.

SLB is the world's premier oilfield-services company as measured by market share. While the industry is mostly fragmented, SLB holds the first or second competitive position in many of the differentiated oligopolies it operates in. Also known as Schlumberger, the company was founded in 1926 by two brothers bearing the same last name. Today it's most known as a global industry leader in innovation, while it focuses its strategy on its three growth engines: its core, digital, and new energy businesses. Over three fourths of its revenue base is tied to international markets, while the company boasts roughly $3 billion in digital-related revenue.

Share on Social Networks: